Clean-Science-and-Technology-Ltd.IPO-Feature-Image

Company Profile: –

Clean Science and Technology Ltd. is engaged in the manufacturing of functionally critical specialty chemicals such as Performance Chemicals comprising MEHQ, BHA and Ascorbyl Palmitate, Pharmaceutical Intermediates comprising Guaiacol and DCC and FMCG Chemicals comprising 4- MAP and Anisole. Company’s products are used as Key Raw materials cater to a diverse base of customers across industries.  Globally the company is the largest manufacturer of MEHQ, BHA, Anisole and 4-MAP in terms manufacturing capacities as on December 31, 2020. MEHQ is the Polymerization inhibitor that finds its application in Acrylic fibers, inks, Agrochemicals, cosmetic and topical drugs, BHA is Used as a synthetic antioxidant in Food packaging, animal feed, rubber, cosmetics and petroleum products, 4-MAP is a specialty chemical with UV blocker properties, primarily used in the cosmetics industry and Anisole is supplied by the company as a key starting material for agrochemicals, flavors and fragrance products. Key customers of the company include Bayer AG, SRF Limited, Gennex Laboratories Limited, Nutriad International NV and Vinati Organics Limited. Nearly 66% revenue of company comes from international markets including China, Europe, the United States of America, Taiwan, Korea, and Japan. The company has two certified production facilities located at Kurkumbh (Maharashtra) with a combined installed capacity of 29,900 MTPA as on December 31, 2020.

Open Your Demat Account to Invest in Upcoming IPO’s

open-demat-online

Monthly-Stock-Picks-February-2021

Clean Science and Technology Ltd.

Wants To Apply Online

Positive outlook of the Firm:

  • Globally largest producer of functionally critical specialty chemicals
  • Have long and Strong relationship with key customers
  • Have Automated manufacturing facilities with proven design
  • Among the most profitable specialty chemical companies globally

Objective of the Issue:

  • To carry out the Offer for Sale
  • To achieve the benefits of listing the Equity Shares on the Stock Exchanges

Promoters of the company:

  • Ashok Ramnarayan Boob, Krishnakumar Ramnarayan Boob, Siddhartha Ashok Sikchi and Parth Ashok Maheshwari are the promoters of the company.

Shareholding Pattern:

Particulars Pre-Issue
Promoters & Promoters Group 94.65%
Public 5.35%

Check Clean Science and Technology Ltd. IPO Allotment Status

Clean Science and Technology Ltd. IPO allotment status would be available soon after the IPO closure date. Usually the allotment comes within a week from the closing date which in this IPO yet to be announced.

One can check the allotment on the given below link with PAN number or Application number or DP Client Id. All you need to do is to follow these steps:-

  1. To  Clean Science and Technology Ltd. IPO Allotment Status
  2. Go to Application Status
  3. Select IPO as Clean Science and Technology Ltd.
  4. Enter your PAN Number or Application Id or DP Client Id.

 

Clean Science and Technology Ltd. IPO

Application Form

 

Elite-Empower-App-Promotional-Banner-img1

Summary of the Issue:

Issue Open
Price Band
Issue Type Book Built Offer
Issue Size (Value)
Face Value Rs.1
Issue price
Minimum lot
Market Lot
Stock Exchange NSE,BSE
QIB Portion 50%
NIB Portion 15%
Retail Portion 35%
Fresh Issue
Offer for Sale Rs.1400 Crore.

 

Financials:

Particulars ( in Rs. Cr.) As at/ for the year ended December 31, 2020 As at/ for the year ended March 31, 2020 As at/ for the year ended March 31, 2019 As at/ for the year ended March 31, 2018
Total assets 571 430 327 236
Total revenue 379 419 393 243
Net Profit 145 139 98 49
Net cash inflow/ (outflows) 6 (1.6) (21) (23)

 

Lead Manager Details

1)  Axis Capital

10th Axis Capital Limited, 1st floor, Axis House, C-2 Wadia International Centre, P.B. Marg, Worli, Mumbai 400 025, Maharashtra, India

Tel: +91 22 4325 2183

E-mail: cleanscience.ipo@axiscap.in

Website: www.axiscapital.co.in

Investor Grievance ID: complaints@axiscap.in

Contact Person: Sagar Jatakiya

SEBI Registration Number: INM000012029

2) Link Intime India Private Limited

C-101, 1st floor, 247 Park,L.B.S. Marg, Vikhroli (West),Mumbai 400 083

Tel: +91 22 49186200

E-mail: cleanscience.ipo@linkintime.co.in

Website: www.linkintime.co.in

Investor Grievance ID: cleanscience.ipo@linkintime.co.in

Contact Person: Shanti Gopalkrishnan

SEBI Registration Number.: INR000004058

3) JM Financial Limited

7th Floor, Cnergy Appasaheb Marathe MargPrabhadevi, Mumbai, Maharashtra – 400025, India

Tel: +91 22 6630 3030

E-mail: cleanscience.ipo@jmfl.com

Website: www.jmfl.com

Investor Grievance ID: grievance.ibd@jmfl.com

Contact Person: Prachee Dhuri

SEBI Registration Number: INM000010361

4) Kotak Investment Banking

Kotak Mahindra Capital Company Limited, 1st Floor, 27 BKC, Plot No. 27, ‘G’ Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051, Maharashtra, India

Tel: +91 22 4336 0000

E-mail: cleanscience.ipo@kotak.com

Website: www.investmentbank.kotak.com

Investor Grievance ID: kmccredressal@kotak.com

Contact Person: Ganesh Rane

SEBI Registration Number: INM000008704

(Source:DRHP)

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth
Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their
investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth
Limited are registered/qualified as research analysts with SEBI in India. (SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Manoj Vijay Shinde, Elite Wealth Limited, manojshinde@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their
securities. I/We also certify that no part of my compensation was, is or will be, directly or inirectly, related to the specific recommendations or views expressed in this
report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that
the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the
report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment
thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing
research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research.
For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure
documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available
to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of
coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth
Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, advisory board member or employee of any company
in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. RavinderParkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course
Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and
Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL Advisory discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research
report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL Advisory or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL Advisory or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of
the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL Advisory or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public
appearance;
2. Compensation
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL Advisory or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL Advisory or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company
in the past twelve months;
(d) EWL Advisory or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage
services from the subject company in the past twelve months;
(e) EWL Advisory or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research
report.
3 In respect of Public Appearances
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided
by EWL Advisory
Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of
clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or
brokerage services transactions of the subject company.
(4) EWL Advisory or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL Advisory has never been engaged in market making activity for the subject company;
(6) EWL Advisory shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.